Ahead of the company’s second-quarter earnings call Aug. 6, Oscar Health is slashing its full-year guidance by about half a ...

Oscar Health, Inc. ("Oscar" or the "Company") (NYSE: OSCR), a leading healthcare technology company, announced today certain ...

Oscar Health, Inc. (OSCR) closed at $14.20 in the latest trading session, marking a -10.52% move from the prior day. The stock fell short of the S&P 500, which registered a gain of 0.07% for the day.

Oscar Health (NYSE:OSCR) stock fell 3.5% after the healthcare technology company revised its 2025 financial guidance following a review of second quarter Marketplace data that revealed ...

Oscar's strong revenue growth, improving profitability, and efficient SG&A management support my positive outlook. Read why ...

Oscar Health (NYSE:OSCR) shares rose 7% premarket on Tuesday after the company revised its full-year sales outlook. The ...

The health insurance agency said Tuesday it now expects a medical loss ratio of 86% to 87% for the full year, with total revenue now seen at $12 billion to $12.2 billion and a loss from operations of ...

Is OSCR in Good Health? Oscar Health (NYSE:OSCR) is a technology-driven health insurance company specializing in individual, ...

Investing.com -- Oscar Health has increased its full-year revenue forecast to between $12 billion and $12.2 billion, up from its previous guidance of $11.20 billion to $11.30 billion. This new outlook ...

While Oscar Health has been reeling from Trump's "Beautiful" bill, the underlying low-cost offering could help lift OSCR ...

Oscar Health 's (OSCR-9.71%) initial public offering has proven to be a major flop despite having a top-rated health insurance business. Over the past six weeks, ...

Oscar Health (OSCR 1.54%) has fallen over 70% since it went public this March. But the stock is deeply misunderstood. Oscar may now be one of the best long-term U.S. technology investments ...